• 1. Emerging investigator series: kinetics of diopside reactivity for carbon mineralization in mafic–ultramafic rocks
  BrianaAguila,LandonHardee,H.ToddSchaef,SiavashZare,MohammadJavadAbdolhosseiniQomi,JarrodV.Crum,JadeE.HollimanJr.,ElenaTajueloRodriguez,LawrenceM.Anovitz,KevinM.Rosso,QuinR.S.Miller
• 2. Excellent mechanical performance and enhanced dielectric properties of OBC/SiO2 elastomeric nanocomposites: effect of dispersion of the SiO2 nanoparticles?
  Xing Zhao,Lu Bai,Rui-Ying Bao,Zheng-Ying Liu,Ming-Bo Yang,Wei Yang RSC Adv., 2017,7, 46297-46305
• 3. Ester-mediated peptide formation promoted by deep eutectic solvents: a facile pathway to proto-peptides?
  Chen-Yu Chien,Sheng-Sheng Yu Chem. Commun., 2020,56, 11949-11952
• 4. Examination of the hydrogen-bonding networks in small water clusters (n = 2–5, 13, 17) using absolutely localized molecular orbital energy decomposition analysis?
  Erika A. Cobar,Paul R. Horn,Robert G. Bergman,Martin Head-Gordon Phys. Chem. Chem. Phys., 2012,14, 15328-15339
• 5. Embedding cyclic nitrone in mesoporous silica particles for EPR spin trapping of superoxide and other radicals?
  Eric Besson,Stéphane Gastaldi,Emily Bloch,Selma Aslan,Hakim Karoui,Olivier Ouari,Micael Hardy Analyst, 2019,144, 4194-4203

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azoles Pyrazole carboxylic acids and derivatives
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azoles Pyrazoles Pyrazole carboxylic acids and derivatives

Methyl 3-methoxy-1-methyl-1H-pyrazole-5-carboxylate (CAS No. 55781-86-7): A Comprehensive Overview

Methyl 3-methoxy-1-methyl-1H-pyrazole-5-carboxylate, identified by its CAS number 55781-86-7, is a significant compound in the field of pharmaceutical chemistry and bioorganic synthesis. This heterocyclic ester has garnered attention due to its versatile structural framework and potential applications in drug development, particularly in the synthesis of novel therapeutic agents.

The compound belongs to the pyrazole class of heterocycles, which are widely recognized for their broad spectrum of biological activities. Pyrazoles exhibit a unique combination of electronic and steric properties that make them valuable scaffolds for medicinal chemistry. The presence of both methoxy and methyl substituents in the molecule enhances its reactivity and functionalization possibilities, opening up numerous synthetic pathways.

In recent years, there has been a surge in research focusing on pyrazole derivatives due to their demonstrated efficacy in various therapeutic areas. Studies have highlighted the potential of these compounds as anti-inflammatory, antiviral, anticancer, and antimicrobial agents. The ester functionality in Methyl 3-methoxy-1-methyl-1H-pyrazole-5-carboxylate further contributes to its utility, as esters can be readily modified through hydrolysis or transesterification reactions to yield different pharmacophores.

One of the most compelling aspects of this compound is its role as a building block in the synthesis of more complex molecules. Researchers have leveraged its structural features to develop novel analogs with enhanced pharmacological properties. For instance, modifications at the 3-position methoxy group have been shown to influence binding affinity and metabolic stability, critical factors in drug design.

The synthesis of Methyl 3-methoxy-1-methyl-1H-pyrazole-5-carboxylate typically involves multi-step organic transformations, starting from readily available precursors such as methyl acetoacetate or methyl 3-hydroxypropionate. The reaction sequence often includes condensation reactions followed by esterification, with careful control over reaction conditions to ensure high yields and purity.

Recent advancements in synthetic methodologies have also enabled more efficient routes to this compound. Catalytic processes, including transition metal-catalyzed reactions, have been explored to streamline the synthesis while minimizing byproduct formation. These innovations not only improve scalability but also align with green chemistry principles by reducing waste and energy consumption.

Beyond its synthetic utility, Methyl 3-methoxy-1-methyl-1H-pyrazole-5-carboxylate has been investigated for its potential biological effects. Preliminary studies suggest that it may exhibit inhibitory activity against certain enzymes and receptors implicated in diseases such as cancer and inflammation. While further research is needed to fully elucidate its mechanism of action, these findings underscore its promise as a lead compound for drug discovery.

The compound's structural flexibility also makes it an attractive candidate for structure-based drug design. Computational modeling techniques have been employed to understand how it interacts with biological targets at the molecular level. These insights can guide the optimization process, leading to derivatives with improved efficacy and reduced side effects.

In conclusion, Methyl 3-methoxy-1-methyl-1H-pyrazole-5-carboxylate (CAS No. 55781-86-7) represents a valuable asset in pharmaceutical research and development. Its unique structural features, coupled with its synthetic accessibility and biological potential, position it as a key intermediate for creating novel therapeutic agents. As research continues to uncover new applications for this compound, it is likely to remain a cornerstone in medicinal chemistry endeavors.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)